Research graph
References from Use of antiviral drugs and incidence of Parkinson’s disease in Taiwan. Local targets link to admitted publications; unresolved targets remain external evidence.
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson’s disease, a triggering role in the disease
10.1016/j.jneuroim.2016.01.007 · 2016 · External reference
Herpesvirus infections and risk of Parkinson’s disease.
10.1159/000512874 · 2020 · External reference
The neurotropic herpes viruses: herpes simplex and varicella-zoster
10.1016/s1474-4422(07)70267-3 · 2007 · External reference
Interface between tauopathies and synucleinopathies: a tale of two proteins
10.1002/ana.20819 · 2006 · External reference
Herpes zoster correlates with increased risk of Parkinson’s disease in older people: A population-based cohort study in Taiwan.
10.1097/md.0000000000006075 · 2017 · External reference
Infectious Microorganisms Seen as Etiologic Agents in Parkinson’s Disease.
2023 · External reference
Risk of Parkinson’s disease among patients with herpes zoster: a nationwide longitudinal study.
10.1017/s1092852919001664 · 2020 · External reference
Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases.
10.1002/ana.10662 · 2003 · External reference
Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection
10.1001/jamaneurol.2019.1368 · 2019 · External reference
Unresolved reference
External reference
Real-world evidence—what is it and what can it tell us?.
10.1056/nejmsb1609216 · 2016 · External reference
Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA working group. Italian longitudinal study on aging
10.1212/wnl.55.9.1358 · 2000 · External reference
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
10.1212/wnl.52.6.1214 · 1999 · External reference
Cardiovascular risk factors and Parkinson’s disease in 500,000 Chinese adults.
10.1002/acn3.732 · 2019 · External reference
Time trends in the prevalence and incidence of Parkinson’s disease in Taiwan: A nationwide, population-based study
10.1016/j.jfma.2015.05.014 · 2016 · External reference
Socioeconomic status in relation to Parkinson’s disease risk and mortality: A population-based prospective study.
10.1097/md.0000000000004337 · 2016 · External reference
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson’s disease: what do prospective studies suggest
10.1016/j.nbd.2019.104671 · 2020 · External reference
Association between Parkinson’s disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis.
10.1371/journal.pone.0151841 · 2016 · External reference
Parkinson’s disease and pesticides: a toxicological perspective
10.1016/j.tips.2008.03.007 · 2008 · External reference
Exposure to pesticides or solvents and risk of Parkinson disease
10.1212/wnl.0b013e318294b3c8 · 2013 · External reference
Associations between cerebrovascular risk factors and Parkinson disease
10.1002/ana.25564 · 2019 · External reference
Stroke and coronary artery disease are associated with Parkinson’s disease
10.1017/cjn.2018.56 · 2018 · External reference
Migraine is related to an increased risk of Parkinson’s disease: A population-based, propensity score-matched, longitudinal follow-up study.
10.1177/0333102416630577 · 2016 · External reference
Autoimmune disease associated CLEC16A variants convey risk of Parkinson’s disease in Han Chinese.
10.3389/fgene.2022.856493 · 2022 · External reference
Cancer risk in Parkinson disease: an updated systematic review and meta-analysis
10.1111/ene.15069 · 2021 · External reference
Association between hypertension and the risk of Parkinson’s disease: A meta-analysis of analytical studies
10.1159/000496977 · 2019 · External reference
Risk of Parkinson disease in diabetes mellitus: an updated meta-analysis of population-based cohort studies
10.1097/md.0000000000003549 · 2016 · External reference
Association between depression and the subsequent risk of Parkinson’s disease: A meta-analysis
10.1016/j.pnpbp.2018.05.025 · 2018 · External reference
Bacterial, viral, and fungal infection-related risk of Parkinson’s disease: meta-analysis of cohort and case-control studies
10.1002/brb3.1549 · 2020 · External reference
Hepatitis C virus infection and risk of Parkinson’s disease: a systematic review and meta-analysis
10.1097/meg.0000000000000991 · 2018 · External reference
The association between vitamin D status, vitamin D supplementation, sunlight exposure, and Parkinson’s disease: A systematic review and meta-analysis
10.12659/msm.912840 · 2019 · External reference
Head injury and risk of Parkinson disease: a systematic review and meta-analysis
10.1002/mds.25458 · 2013 · External reference
Association between anemia and risk of Parkinson disease.
2021 · External reference
Association between stroke and Parkinson’s disease: a meta-analysis
10.1007/s12031-020-01524-9 · 2020 · External reference
Non-genetic risk factors for Parkinson’s disease: an overview of 46 systematic reviews.
10.3233/jpd-202521 · 2021 · External reference
Nicotine promotes neuron survival and partially protects from Parkinson’s disease by suppressing SIRT6
10.1186/s40478-018-0625-y · 2018 · External reference
Nicotine as a potential neuroprotective agent for Parkinson’s disease
10.1002/mds.25028 · 2012 · External reference
Inflammation and immune dysfunction in Parkinson disease
10.1038/s41577-022-00684-6 · 2022 · External reference
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation
10.1099/vir.0.000128 · 2015 · External reference
Virus infections in the nervous system
10.1016/j.chom.2013.03.010 · 2013 · External reference
Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons
10.1038/cddis.2015.166 · 2015 · External reference
Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virus.
10.3389/fnagi.2014.00202 · 2014 · External reference
Considering sex and gender in Alzheimer disease and other dementias.
10.31887/dcns.2016.18.4/cepperson · 2016 · External reference
Sex differences in progression to mild cognitive impairment and dementia in Parkinson’s disease
10.1016/j.parkreldis.2018.02.007 · 2018 · External reference
Unresolved reference
2019 · External reference
Alzheimer’s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease
10.1002/ana.24135 · 2014 · External reference
Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study
10.1212/wnl.0b013e3181d31e5c · 2010 · External reference
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine
10.1086/605611 · 2009 · External reference
Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease.
10.1186/s12974-023-02759-0 · 2023 · External reference
Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?.
10.3389/fnins.2020.580311 · 2020 · External reference
Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study
10.1001/archneur.61.1.82 · 2004 · External reference
Insights of Valacyclovir in Treatment of Alzheimer’s Disease: Computational Docking Studies and Scopolamine Rat Model.
10.2174/1567202619666220908125125 · 2022 · External reference
Cognitive outcome in acute sporadic encephalitis.
10.1023/a:1009079531196 · 2000 · External reference
